Catherine Safran

 Catherine Safran

Catherine Safran

  • Courses3
  • Reviews25
Apr 30, 2018
N/A
Textbook used: No
Would take again: Yes
For Credit: Yes

0
0


Mandatory



Difficulty
Clarity
Helpfulness

Awesome

Professor Safran is such a sweet lady. I enrolled in her class for both BISC 208 AND BISC 276. She can sometimes be hard to understand but she is always willing to help you and she knows what she is talking about. If you review the slides beforehand and the in class activities then the exams won't be too bad, plus the clicker quizzes boost your grade.

Biography

University of Delaware - Biology


Resume

  • 1990

    Doctor of Philosophy (Ph.D.)

    Dissertation title: Effects of matrix constituents and growth factors on odontoblast differentiation.

    Developmental Biology

    University of Strasbourg

  • 1989

    French

    Master of Science (MS)

    Cellular and Molecular Biology

    University of Strasbourg

  • 1986

    Bachelor of Science (B.S.)

    Studied Physiology

    Cellular Biology

    and Molecular Biology at the undergraduate level.

    Biology and Biochemistry

    University of Strasbourg

    Northeast Summer Institute on Scientific Teaching -University of Connecticut

    Storrs

    CT

    Molecular Embryology of the Mouse Course

    Cold Spring Harbor

  • 944

    Injectable Delivery System for Heparin-Binding Growth Factors

    us

    14/004

    Jia X

  • The CIRTL Network

    Dog walking

    Delaware Humane Association

    Mentor

    The Summer Institutes on Scientific Teaching

    Molecular Genetics

    qPCR

    Bone and Cartilage Diseases

    Western Blotting

    Tooth development

    Molecular Biology

    Cell Culture

    Transgenics

    Biomechanics

    Life Sciences

    Clinical Development

    Embryonic Stem Cells

    PCR

    Confocal Microscopy

    Mouse Models

    HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation.

    AJ Brown

    HIP is a heparin/heparan sulfate (Hp/HS) binding protein identical to ribosomal protein L29 that displays diverse biological functions. There is strong evidence that abnormal expression and quantitative deficiencies of essential molecules such as extracellular matrix (ECM) proteins and ribosomal proteins can seriously impair embryonic development. As observed for HS-bearing molecules

    high levels of HIP/RPL29 are found in proliferating chondrocytic precursors and chondrocytes of developing growth plate. Here

    we demonstrate both in vitro and in developing mouse embryos that HIP/RPL29 is down-regulated in terminally differentiated chondrocytes corresponding to the late hypertrophic zone of the growth plate. Because cartilage serves as a template for endochondral bone formation

    we hypothesize that the presence of HIP/RPL29 during early chondrogenesis is essential for normal skeletal growth and patterning. In particular

    we believe that HIP/RPL29 expression is required to maintain proliferation of chondrocytes and avoid skeletal shortening. Increasing evidence suggests that multifunctional ribosomal proteins of eukaryotic cells are important regulators of cell growth and differentiation

    not simply structural parts of translational machinery. To investigate the role of HIP/RPL29 normal expression during cartilage formation

    we designed a ribozyme-mediated knock-down approach to partially down-regulate HIP/RPL29 expression in the mouse embryonic skin fibroblast cell line C3H/10T (1/2). This technology permitted us to avoid the insufficient expression associated with more severe consequences

    such as lethality

    and provided advantages similar to those obtained with mutations generating hypomorphic phenotypes. Our results show that partial reduction of HIP/RPL29 levels accelerates differentiation of C3H/10T(1/2) into cartilage-like cells. In conclusion

    our data indicate that HIP/RPL29 constitutes an important novel regulator of chondrocytic growth and differentiation.

    HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation.

    Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system

    Mary C. Farach-Carson

    Xinqiao Jia

    Weidong Yang

    Amit Jha

    Padma Srinivasan

    Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis

    Perlecan

    a heparan sulfate proteoglycan

    acts as a mechanical sensor for bone to detect external loading. Deficiency of perlecan increases the risk of osteoporosis in patients with Schwartz-Jampel Syndrome (SJS) and attenuates loading-induced bone formation in perlecan deficient mice (Hypo). Considering that intracellular calcium [Ca2+]i is an ubiquitous messenger controlling numerous cellular processes including mechanotransduction

    we hypothesized that perlecan deficiency impairs bone's calcium signaling in response to loading. To test this

    we performed real-time [Ca2+]i imaging on in situ osteocytes of adult murine tibiae under cyclic loading (8N). Relative to wild type (WT)

    Hypo osteocytes showed decreases in the overall [Ca2+]i response rate (-58%)

    calcium peaks (-33%)

    cells with multiple peaks (-53%)

    peak magnitude (-6.8%)

    and recovery speed to baseline (-23%). RNA sequencing and pathway analysis of tibiae from mice subjected to one or seven days of unilateral loading demonstrated that perlecan deficiency significantly suppressed the calcium signaling

    ECM-receptor interaction

    and focal adhesion pathways following repetitive loading. Defects in the endoplasmic reticulum (ER) calcium cycling regulators such as Ryr1/ryanodine receptors and Atp2a1/Serca1 calcium pumps were identified in Hypo bones. Taken together

    impaired calcium signaling may contribute to bone's reduced anabolic response to loading

    underlying the osteoporosis risk for the SJS patients.

    Perlecan/Hspg2 deficiency impairs bone's calcium signaling and associated transcriptome in response to mechanical loading.

    Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.

    Inhibition of T-Type Voltage Sensitive Calcium Channel Reduces Load-Induced OA in Mice and Suppresses the Catabolic Effect of Bone Mechanical Stress on Chondrocytes

    Erica Selva

    William Thompson

    Padma Srinivasan

    Kerry Falgowski

    Sarah McCoy

    Serum xylosyltransferase 1 level increases during early posttraumatic osteoarthritis in mice with high bone forming potential

    Randy Duncan

    Mary (Cindy) Farach-Carsonran

    Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.

    MD Anderson Cancer Center

    The University of Texas Health Science Center at Houston (UTHealth) School of Dentistry

    University of Delaware

    Widener University

    Newark

    Teaching

    Academic Advising

    Mentoring

    Leading Research Projects

    Publishing in Peer-Reviewed Journals

    Serving as Peer-Reviewer for various Scientific Journals.

    Assistant Professor

    University of Delaware

    Molecular Genetics

    MD Anderson Cancer Center

    Widener University

    Chester

    Pennsylvania

    Assistant Teaching Professor of Biology

    Newark

    Mentoring Graduate and Undergraduate Students

    Leading Research Projects

    Publishing in Peer-Reviewed Journals

    Serving as Peer-Reviewer for various Scientific Journals.

    Research Assistant Professor

    University of Delaware

    Transgenic Research

    University of Delaware

    Post Doctoral Research

    Skeletal Biology

    The University of Texas Health Science Center at Houston (UTHealth) School of Dentistry

208

3.9(4)

Popular!

BISC 208

4.1(19)

BISC 276

3.5(2)